Alerts
COVID-19 update

We follow the Kansas Department of Health and Environment's phased vaccination distribution plan. Visit our vaccine updates page often for the latest information.

Skip Navigation

Oncology Pharmacy Residency

The oncology pharmacy practice residency at The University of Kansas Health System provides residents with the skills and knowledge to become competent oncology/hematology pharmacy practitioners. The focus of the residency program is adult hematology and oncology, with experiences in hematopoietic stem cell transplantation and ambulatory oncology practice settings.

Residency program purpose statement

The purpose of the oncology pharmacy residency program – designed for second-year postgraduates (PGY2) – centers on the development of the knowledge, attitudes and skills needed to become a well-rounded oncology practitioner able to successfully practice in many different settings. It focuses upon development of special competence in applying pharmacotherapeutic intervention in cancer patients. This residency will provide educational and training experiences for pharmacists in the fundamentals of oncology pharmacy practice in an integrated healthcare system. Through various clinical, practice management and pharmaceutical practice training segments, the residency instills a philosophy of practice that embraces the concept that pharmacists must be accountable for optimum drug therapy outcomes and act as leaders in advancing care of patients.

Length of program: 12 months, starting July

Number of positions: 4

Current benefits

  • Annual salary: $48,000
  • Benefits include PTO, paid holidays, health/dental/life/liability insurance
  • View more information

Contact us

The University of Kansas Cancer Center
Pharmacy
2330 Shawnee Mission Pkwy., Suite 201N, Mailstop 5028
Westwood, KS 66205
Zahra Mahmoudjafari

PGY2 Oncology residency director

Zahra Mahmoudjafari, PharmD, BCOP, DPLA

Phone: 913-945-8167

Meet our residents

Jordanne Adolphsen

Jordanne Adolphsen, PGY2: Oncology

Hometown: Batesville, Indiana

Pharmacy school: The University of Kansas School of Pharmacy

PGY1: Wesley Medical Center

Clinical interests: Hematology/BMT, pharmacogenomics

Hobbies: Landscaping, playing/watching sports, trying local restaurants

Research project: Analysis of Outcomes Between Patients with Homologous Recombination Deficiency Mutations Receiving Poly (ADP-ribose) Polymerase Inhibitors for Ovarian Cancer

Why I chose The University of Kansas Health System: I chose The University of Kansas Health System for its integration of pharmacy into direct patient care and comprehensive clinical experiences. It offered the opportunity to participate in a learning environment that would not only challenge me clinically, but also support and help me grow as a new practitioner, preceptor and leader.

Russell Clark

Russell Clark, PGY2: Oncology

Hometown: Houston, Texas

Pharmacy school: Texas A&M University Irma Lerma Rangel College of Pharmacy

PGY1: CHI St. Luke's Health – Baylor St. Luke’s Medical Center

Clinical interests: Hematology/Oncology

Hobbies: Basketball, running, reading and astronomy

Research project: Analysis of Lymphocyte Count Association with Response and IRAEs in Patients Receiving Immunotherapy

Why I chose The University of Kansas Health System: I was advised to consider The University of Kansas Health System by mentors and respected hem/onc pharmacists based on their administrative proficiency, organizational structure and training capabilities. Meeting with the pharmacy team during my interview, I saw all 3 of those qualities and more. The "more" is how quickly I felt the fit with the program; I wanted to work with this pharmacy department. This is clearly an excellent program to receive training, with high-quality preceptors and extensive patient populations from which to gain knowledge and experience.

Liz Hazlett

Liz Hazlett, PGY2: Oncology

Pharmacy school: The University of Kansas School of Pharmacy

PGY1: The University of Kansas Health System

Clinical interests: Oncology/Solid tumor

Hobbies: KU basketball, the Chiefs (a.k.a. Superbowl 2020 Champs), cooking, all dogs

Research project: Letermovir for CMV Prevention in Haploidentical Allogeneic Transplant Patients – a Single Center Experience

Why I chose The University of Kansas Health System: The University of Kansas Health System has the most progressive and respected pharmacy department of any institution I have seen, as well as a complex patient population that provides many opportunities for learning and direct patient care. The advanced hematology/oncology program and continual growth of both inpatient and outpatient cancer care services also make this the perfect institution to complete a PGY2.

Michael Weise

Michael Weise, PGY2: Oncology

Hometown: Lee’s Summit, Missouri

Pharmacy school: Creighton University School of Pharmacy and Health Professions

PGY1: Mosaic Life Care

Clinical interests: Hematology/Oncology

Hobbies: Kayaking, hiking, cooking and watching true crime documentaries

Research project: Incidence of Febrile Neutropenia in Patients with Breast Cancer Receiving Same-Day vs Next-Day Pegfilgrastim

Why I chose The University of Kansas Health System: I chose The University of Kansas Health System because of the people. The entire cancer care team is welcoming and focused on fostering a culture of both professional and personal growth. Additionally, the pharmacists are extremely valued and have prominent roles as members of the patient care team.

The oncology pharmacy residency learning experience

Our cancer center, The University of Kansas Cancer Center, is one of only 71 National Cancer Institute-designated cancer centers in the nation. It has been NCI-designated since 2012. The cancer program has also been recognized each year since 2011 by U.S. News & World Report.

Additional facts about the cancer center include:

  • More than 45 cancer care clinical pharmacists on staff
  • Clinical Research Center focuses on early preclinical and phase I trials
  • Accredited by the American College of Surgeons Commission on Cancer since 1934
  • QOPI®-certified practice
  • URAC accredited
  • More than 300 hematopoietic stem cell transplants performed annually
  • FACT-accredited (immune effector cell, BMT auto/allo program)
  • National Marrow Donor Program-accredited
  • Certified CAR T-cell therapy center for commercial and investigational products

Practice areas

The specialty residency in hematology/oncology is tailored to the interests and career goals of each resident. A variety of practice settings are available. Required rotations are listed below:

  • Orientation (1 month)
  • Inpatient/Outpatient adult hematology (6 weeks)
  • Inpatient/Outpatient adult gynecologic oncology (6 weeks)
  • Inpatient adult acute leukemia (1 month)
  • Inpatient adult allogeneic hematopoietic stem cell transplant (1 month)
  • Outpatient adult hematopoietic stem cell transplant clinic (1 month)
  • Outpatient infusion cancer pharmacy (1 month)
  • Outpatient gastrointestinal malignancy clinic (1 month)
  • Clinical research (1 month)
  • Inpatient adult hematology advanced independent practice (AIP) (1 month)
    • The AIP rotation is a 4-week experience in which the resident covers a service independently. The goal is for the resident to gain the confidence and experience of covering a service independently prior to entering the workforce. This is done once the resident has sufficient experience in an area of practice.
  • Elective (2-3 months)
  • Longitudinal administration
    • The resident will participate in a longitudinal administrative rotation beginning in September of the residency year. This rotation will be scheduled for 2 days per month and the resident will be excused from clinical rotation. This rotation is designed to incorporate many aspects of practice leadership in the area of cancer.

Elective rotations

Any of the required rotations may be repeated as elective rotations. Rotations will last for 4-6 weeks unless approved by the residency director.

Elective rotations are designed to provide training in areas of interest. Examples of the options available include:

  • Oncology administration
  • Outpatient hematology clinic
  • Palliative care
  • Infectious disease
  • Gynecology/oncology outpatient clinic
  • Melanoma outpatient clinic
  • Cancer center community locations

Staffing requirement

The PGY2 oncology resident will staff 1 weekday evening (4-7 p.m.) in the outpatient cancer center pharmacy beginning in October and work every 3 weekends (Saturday and Sunday) in the outpatient cancer center pharmacy, alternating with staff independently with the hematology inpatient rounding service.

Longitudinal experiences

  • Research
    • Present results of major research project at the Midwest Pharmacy Residents Conference and prepare a manuscript for publication
  • Projects and presentations
    • Formal presentation in September to cancer care pharmacy team
    • Hematology/Oncology Pharmacy Association in March/April
    • Midwest Residency Conference in May
    • Pharmacy grand rounds
    • Oncology topic discussions (every 4 weeks)
  • Teaching
    • Residents will have the opportunity to precept students from both the University of Kansas and University of Missouri – Kansas City schools of pharmacy on clinical rotations. Residents will also have the opportunity to gain teaching experience in classrooms through the hematology/oncology pharmacotherapy lecture series for University of Kansas School of Pharmacy students. An optional teaching certificate program is available for residents with an interest in teaching. The program includes seminars on how to teach, experiential components for didactic and small group teaching, and compiling a teaching portfolio.

Application information

PhORCAS

Deadlines

  • Application deadline: Please refer to residency listing on ASHP website.
  • Must have a valid pharmacy license in the state of Kansas prior to residency start date or July 15 at latest.

Checklist for application

National matching services (NMS) code: 618660

We are an equal employment opportunity employer without regard to a person’s race, color, religion, sex (including pregnancy, gender identity and sexual orientation), national origin, ancestry, age (40 or older), disability, veteran status or genetic information.

Related links